Udayavni Special

PM reviews COVID-19 vaccine delivery programme, priority groups being identified


PTI, Nov 21, 2020, 8:46 AM IST

New Delhi: Prime Minister Narendra Modi on Friday held a meeting to review India’s COVID-19 vaccination strategy in which issues like prioritisation of population groups, including health and other frontline workers, and tech platform for rolling out the vaccine were discussed.

Modi tweeted that the meeting discussed important issues related to progress of vaccine development, regulatory approvals and procurement.

“Reviewed various issues like prioritisation of population groups, reaching out to HCWs (health care workers), cold-chain infrastructure augmentation, adding vaccinators and tech platform for vaccine roll-out,” he said.

The prime minister directed that a time-bound plan be laid out for speedy regulatory clearances and timely procurement for early roll-out of the vaccination drive when a vaccine becomes available, an official statement later said.

Database, cold chain augmentation and transportation mechanisms are being readied, with digital platform for vaccine delivery and monitoring being prepared and tested in consultation with all stakeholders, it said.

Modi also reviewed the aspects of emergency use authorisation and for manufacture and procurement of medicine.

As the results of phase-III trials from national and international vaccine arrive, our robust and independent regulators will speedily and rigorously examine these for according authorisation for use, the statement said.

Five vaccine candidates are in advanced stages of development in India, out of which four are in Phase II/III and one is in Phase-I/II.

Countries such as Bangladesh, Myanmar, Qatar, Bhutan, Switzerland, Bahrain, Austria and South Korea have shown keen interest in partnering for vaccine development of Indian vaccines and use, the statement said.

In the meeting, the prime minister appreciated the efforts of innovators, scientists, academicians and pharma companies to develop vaccines and directed that every effort should be made to facilitate research, development and manufacturing of the vaccine.

In an effort to administer the vaccine at the first available opportunity, database of healthcare and frontline workers, augmentation of cold chains and procurement of syringes and needles among other items are in advanced stages of preparation, it said.

The vaccination supply chain is being enhanced and non-vaccine supplies are being escalated. Medical and nursing students and faculty will be involved in training and implementation of the vaccination programme.

Every step is being steadily put in place to ensure that vaccines reach every location and person according to the prioritisation principles, the statement said.

“The prime minister has directed to work in collaboration with all reputed national and international institutions and regulators to ensure the rigour and highest global standards in Indian research and manufacturing,” it said.

The National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) in consultation with state governments and all relevant stakeholders has accelerated the implementation of vaccination of priority groups in the first phase, the statement said.

“The digital platform for vaccine administration and distribution is prepared and test runs underway in partnership with state and district level stakeholders,” it said.

The government has provided an assistance of Rs 900 crore under ”Covid Suraksha Mission” to support research and development of the COVID-19 vaccination.

Appreciating the comprehensive efforts on vaccine development, Modi also emphasised that given the persisting pandemic scenario there is no place for any relaxation in preventive measures such as wearing masks, keeping distance and ensuring hygiene.

The meeting was attended by the principal secretary to the prime minister, cabinet secretary, member (health) NITI Aayog, principal scientific advisor, secretary health, DG ICMR, officers of the PMO, and secretaries of related departments of the government of India, the statement said.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

ADB approves $190 mn loan to upgrade Bengaluru’s power distribution system

India beat Australia by 11 runs in first T20 International

SC sends notice to K’taka govt over Ragini’s bail plea in drugs case

K’taka: Expert panel recommends banning New Year public celebrations

COVID-19 vaccination drive after scientists’ nod: PM Modi

Indian Navy an outstanding force: Defence Minister Rajnath Singh on Navy Day

1,525 kg of explosives, 6,000 detonators seized in Meghalaya, 6 arrested



Related Articles More

K’taka COVID-19 update: 1247 new cases, 877 discharges, 13 dead on Dec 3

Moderna’s COVID-19 vaccine helps antibodies last for 3 months: Study

Zydus Cadila Gets DGCI Nod for Phase 3 Covid Vaccine Clinical Trials with Biological Therapy

COVID-19 caseload in India rises to 95.71 lakh with 36,595 new infections

K’taka COVID-19 update: 1446 new cases, 894 discharges, 13 dead on Dec 2

MUST WATCH

M’luru boat tragedy: Search operation still on for Ansar’s body

Deer falls into well, rescued

Without sulking from his illness, this young man changed his life through agriculture

State government must immediately bring in anti-cow slaughter law: Sri Vishwa Prasanna Tirtha Swamiji

Hamsa Chaitanya Desi Outlet | Desi Products Store Udupi | Documentary by Udayavani

Latest Additions

Chargesheet Filed Against Arnab Goswami, Two Others in 2018 Abetment to Suicide Case

Govt Procures 330 Lakh Tonnes of Kharif Paddy So Far at MSP for Over Rs 62,278 Crore

India Economy Likely to Contract by 10% in FY21, Says Former Planning Commission Member Abhijit Sen

K’taka COVID-19 update: 1247 new cases, 877 discharges, 13 dead on Dec 3

Vijay Mallya’s Property in France Worth Rs 14 Crore Seized under PMLA: ED

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.